GLOMERULOESCLEROSIS FOCAL Y SEGMENTARIA TRATAMIENTO PDF

Esclerosis Focal Segmentaria – Es una lesión no un diagnóstico Presentación del tema: “Glomeruloesclerosis Focal y Segmentaria en el Adulto”— Transcripción de la presentación: .. Tratamiento de la Osteoporosis Calcio/ Vitamina D. El tratamiento con esteroides, con antihipertensivos y los depósitos glomerulares de IgM Conclusiones: En glomeruloesclerosis focal y segmentaria primaria. La mitad de los enfermos con síndrome nefrótico causado por glomeruloesclerosis focal y segmentaria (GFS) primaria presentan resistencia al tratamiento con.

Author: Masar Mall
Country: Serbia
Language: English (Spanish)
Genre: Politics
Published (Last): 22 February 2004
Pages: 387
PDF File Size: 4.20 Mb
ePub File Size: 15.4 Mb
ISBN: 588-4-32593-580-7
Downloads: 19271
Price: Free* [*Free Regsitration Required]
Uploader: Yozshukree

The use of rituximab in the treatment of steroid-resistant FSGS is based on the hypothesis that the podocyte lesion glomeruloesclerodis caused by an immune-modifiable pathogenic mechanism.

Glomeruloesclerosis Focal y Segmentaria en el Adulto

Ann Intern Med ; Because the remission rate after treatment is similar among patients with glomeruloesclerosos histologic variants, glomeruloesclerowis to therapy cannot be predicted on the basis of histology alone. A clinical trial on children with steroid-resistant FSGS 31 has been published in which the efficacy of CsA is compared with tacrolimus, in both cases with concomitant use of low-dose steroids, and it was concluded that both drugs have similar efficacy with different extrarenal adverse effect profiles and a tendency towards a lower number of exacerbations with tacrolimus.

Kidney transplantation for primary focal segmental glomerulosclerosis: Soluble interleukin-2 receptor in patients with glomerular diseases. N Engl J Med ; A variable though small percentage of patients, after prolonged follow-up, maintain unaltered renal function despite the persistence of nephrotic syndrome.

We studied clinical and histological characteristics at the time of renal biopsy and clinical condition and renal function at the end of follow- up.

  ASSESS AND CORRECT ERIC CRESSEY PDF

Clinical follow-up and home visit were performed in 44 patients Does cytokine gene polymorphism affect steroid responses in idiopathic nephrotic syndrome? On the contrary, relative changes in suPAR levels glomeruloexclerosis independent predictors of the probability of obtaining complete remission after treatment, after adjusting for age, sex, ethnicity, glomerular filtration and baseline suPAR levels.

The collapsing variant of focal segmental glomerulosclerosis in children

Longer treatment is recommended in recurrent cases. Endocytic properties of the M-type kDa receptor for secretory phospholipases A2. Harcourt Brace de Espa?? Two observational studies 43,44 have described favourable results with significant reductions in proteinuria and even total or partial remissions of nephrotic syndrome. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis.

Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Finally, an analysis is made of where current research is heading.

Factors predicting for renal survival in primary focal segmental glomerulosclerosis

The initial response to steroid treatment may orient one towards the type of resistance to some measure. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome. Their only possible indication, though disputable since it is not backed by any evidence, would be the treatment of patients with nephrotic syndrome in which treatment with calcineurin inhibitors or MMF would not be advisable due to the risk of renal or extra-renal toxicity.

Although oncologic treatment regimens included vincristine for four patients, doxorubicin for five patients, cisplatin for two patients, and total-body irradiation for one patient, the only agent common to all patients was pamidronate Aredia.

  CAPTIVE IN HIS BED SANDRA MARTON PDF

In addition, Gulati et al. Collaborative Group of the Soci?? The journal accepts submissions of articles in English and in Spanish languages. Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan.

Am J Anat ; Given that exposure to such high steroid doses for long periods of time can lead to serious toxic effects, and that the majority of patients who will respond show a certain reduction in proteinuria within 14 to 16 weeks, the steroid-resistance criteria can be accepted if there has not been any change in urine protein excretion within weeks or if there has been, the patient persists with nephrotic syndrome after having finished a 6-month treatment cycle.

For these reasons, the results obtained cannot be extrapolated to those patients with primary forms who suffer from nephrotic syndrome that meet formal criteria for steroid resistance. Focal and segmental glomerulosclerosis: Currently, the available information for many of the possible candidates identified to date, above all those discovered using proteomics, are still very preliminary.

In contrast to the adult population, the collapsing variant of FSGS is idiopathic in most children. The treatment did not induce remissions of nephrotic syndrome in any cases nor did it modify the glomerular filtration slope.

Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis.